Publications   |   Conferences    |  Join   |  Sitemap  
Facebook    Twitter     Linkedin     RSS     Google+    BLOG    You Tube

Journal of Genetic Syndromes & Gene Therapy

Double blind review in 2 weeks     Publishing in 72 hours after acceptance     Open Access     High Impact
ISSN: 2157-7412
French Language  |  English

In Association with


Welcome to the Journal

Blum Editor-in-Chief
Kenneth Blum
Department of Psychiatry
University of Florida
Marek Editor-in-Chief
Marek Malecki
President, PBMEF,
San Francisco,

Impact Factor: 3.67*

ICV: 5.29

Genes are the basic physical and functional units of hereditary and are the specific sequences of bases that are carried on chromosomes which encode instruction, ensure the formation of proteins. Deficiency or disorders of genes in cells leads to the genetic disorders resolved with the respected treatment of gene therapies. The different types of viruses used as gene therapy vectors are retroviruses, adenoviruses, adeno-associated viruses, herpes simplex viruses.
Journal of Genetic Syndromes & Gene Therapy is an international, peer-reviewed scientific journal emphasizes the documentation of phenotype analysis, birth defects; infant abnormalities including the various inheritant disorders caused by single mutant genes and the changes that occur due to therapy are heritable. The Journal of Genetic Syndromes and Gene Therapy under Open Access Category conveys the latest research information on identification and analysis of the defective gene, vector development, gene transfer, and provides the readership with current clinical applications for the treatment of diseases and comprehensive reviews on all aspects of genetic disorders and gene therapy.
Journal of Genetic Syndromes & Gene Therapy is using online manuscript submission, review and tracking systems of Editorial Manager System for quality and quick review processing. Review processing is performed by the editorial board members of Journal of Genetic Syndromes and Gene Therapy or outside experts; at least two independent reviewer’s approval followed by editor's approval is required for acceptance of any citable manuscript.

Journal of Genetic Syndromes & Gene Therapy encompasses the continuous coverage of all biological and medical aspects of potential gene therapies for the birth defects along with genetic disorders which include treatments for cancers, arthritis, infectious diseases, inherited diseases like cystic fibrosis and Huntington’s disease, and also genetic abnormalities or deficiencies are treated by incorporating specific engineered genes into the infected cells of patient’s body. The Journal of Genetic Syndromes & Gene Therapy provides reliable information updating online viewers with the modified methods and latest advancements in the field of gene therapy for diverse genetic disorders.


OMICS International Organises 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.


Journal of Genetic Syndromes & Gene Therapy is associated with our international conference "3rd International Conference and Exhibition on Cell & Gene Therapy" (Cell Gene therapy-2014) during October 27-29, 2014, Las Vegas, USA with a theme “Uncover the potential that lies within the cell”. At the forefront cell and gene therapy dives into the latest happenings of the cell – based and genetic technologies and the transdifferentiation progress to treat various diseases. Progressive research domains as of cancer vaccines and their novel significance are showcased which bring into limelight the cutting edge of the field. The Cell and Gene therapy of the coming ages has promised booming results for treating various diseases apparently by using stem cells without causing harmful side effects


Submit manuscript at or send as an e-mail attachment to the Editorial Office at

* Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = X/Y



Recently published articles

Molecular Genetics of Primary Hyperparathyroidism: The Role of Genetic Tests in Differential Diagnosis, Disease Prevention Strategy, and Therapeutic Planning

Francesca Marini, Luisella Cianferotti, Francesca Giusti and Maria Luisa Brandi

Genetics: A Computational Approach, 5th Edition by Benjamin A. Pierce

Abhishek Kumar

Clinicopathologic Findings in Eosinophilic Gastroenteritis: A German Case Series

Michaela Muller, Klaus Keller, Sonja Stallmann and Alexander J Eckardt

Considerations to Calculate Expected Genotypic Frequencies and Formal Statistical Testing of Hardy-Weinberg Assumptions for nonpseudoautosomal X chromosome SNPs

Fernando Pires Hartwig

Hereditary Breast Cancer in Moroccan Populations: BRCA1 & BRCA2 at the Glance

Zafrilla P, Cerda B, Soler A, Xandri JM, Martinez-Cacha A and Mulero J

Hypohidrotic Ectodermal Dysplasia in Association with Athelia

Iveta Dencheva, Ivan Botev and Lyubka Miteva

Hereditary Breast Cancer in Moroccan Populations: BRCA1 & BRCA2 at the Glance

Hassan Ait Benhassou, Nadia Bouchoutrouch, Youssef Amar and Hassan Sefrioui

Targeted Suppression of a Dystrophin Pseudo-exon using Antisense Oligonucleotides

Barrett LW, Fletcher S, Barreo RA, Bellgard MI, Flanigan KM, Wong B and Wilton SD

The LARO-MEN1 Study: A Clinical Experience with Octreotide Long Acting Release in Patients Affected by Multiple Endocrine Neoplasia Type 1 Syndrome

Giusti Francesca, Cioppi Federica, Masi Laura, Cianferotti Luisella and Brandi Maria Luisa

Genetic Transformation of Cells using Physical Methods

Rivera AL, Gómez-Lim M, Fernández F and Loske AM

* Calculation of Unofficial Impact Factor
20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version